Literature DB >> 35112409

A novel nonsense variant in the NFE2L1 transcription factor in a patient with developmental delay, hypotonia, genital anomalies, and failure to thrive.

Julia M Wang1, Daniel V Ho1, Amy Kritzer2, Jefferson Y Chan1.   

Abstract

The NFE2L1 transcription factor (also known as Nrf1 for nuclear factor erythroid 2-related factor-1) is a broadly expressed basic leucine zipper protein that performs a critical role in the cellular stress response pathway. Here, we identified a heterozygous nonsense mutation located in the last exon of the gene that terminates translation prematurely, resulting in the production of a truncated peptide devoid of the carboxyl-terminal region containing the DNA-binding and leucine-zipper dimerization interface of the protein. Variant derivatives were well expressed in vitro, and they inhibited the transactivation function of wild-type proteins in luciferase reporter assays. Our studies suggest that this dominant-negative effect of truncated variants is through the formation of inactive heterodimers with wild-type proteins preventing the expression of its target genes. These findings suggest the potential role of diminished NFE2L1 function as an explanation for the developmental delay, hypotonia, hypospadias, bifid scrotum, and failure to thrive observed in the patient.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  NFE2L1; dominant negative; global developmental delay; nonsense variant; transcription factor

Mesh:

Substances:

Year:  2022        PMID: 35112409      PMCID: PMC8960367          DOI: 10.1002/humu.24337

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  28 in total

Review 1.  Small Maf proteins (MafF, MafG, MafK): History, structure and function.

Authors:  Fumiki Katsuoka; Masayuki Yamamoto
Journal:  Gene       Date:  2016-04-05       Impact factor: 3.688

2.  Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.

Authors:  Jonghyun Kim; Weirong Xing; Jon Wergedal; Jefferson Y Chan; Subburaman Mohan
Journal:  Physiol Genomics       Date:  2009-11-03       Impact factor: 3.107

3.  Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice.

Authors:  J Y Chan; M Kwong; R Lu; J Chang; B Wang; T S Yen; Y W Kan
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

Review 4.  Nuclear Factor Erythroid-2 Like 1 (NFE2L1): Structure, function and regulation.

Authors:  Hyun Min Kim; Jeong Woo Han; Jefferson Y Chan
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

5.  NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1β genes.

Authors:  Yosuke Hirotsu; Nami Hataya; Fumiki Katsuoka; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2012-05-14       Impact factor: 4.272

6.  Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells.

Authors:  Senthil K Radhakrishnan; Candy S Lee; Patrick Young; Anne Beskow; Jefferson Y Chan; Raymond J Deshaies
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

7.  Characterization of Nrf1b, a novel isoform of the nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genes.

Authors:  Eric K Kwong; Kyung-Mi Kim; Patrick J Penalosa; Jefferson Y Chan
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

8.  Distinct isoforms of Nrf1 diversely regulate different subsets of its cognate target genes.

Authors:  Meng Wang; Lu Qiu; Xufang Ru; Yijiang Song; Yiguo Zhang
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

9.  Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.

Authors:  Margot A Cousin; Blake A Creighton; Keith A Breau; Rebecca C Spillmann; Erin Torti; Sruthi Dontu; Swarnendu Tripathi; Deepa Ajit; Reginald J Edwards; Simone Afriyie; Julia C Bay; Kathryn M Harper; Alvaro A Beltran; Lorena J Munoz; Liset Falcon Rodriguez; Michael C Stankewich; Richard E Person; Yue Si; Elizabeth A Normand; Amy Blevins; Alison S May; Louise Bier; Vimla Aggarwal; Grazia M S Mancini; Marjon A van Slegtenhorst; Kirsten Cremer; Jessica Becker; Hartmut Engels; Stefan Aretz; Jennifer J MacKenzie; Eva Brilstra; Koen L I van Gassen; Richard H van Jaarsveld; Renske Oegema; Gretchen M Parsons; Paul Mark; Ingo Helbig; Sarah E McKeown; Robert Stratton; Benjamin Cogne; Bertrand Isidor; Pilar Cacheiro; Damian Smedley; Helen V Firth; Tatjana Bierhals; Katja Kloth; Deike Weiss; Cecilia Fairley; Joseph T Shieh; Amy Kritzer; Parul Jayakar; Evangeline Kurtz-Nelson; Raphael A Bernier; Tianyun Wang; Evan E Eichler; Ingrid M B H van de Laar; Allyn McConkie-Rosell; Marie T McDonald; Jennifer Kemppainen; Brendan C Lanpher; Laura E Schultz-Rogers; Lauren B Gunderson; Pavel N Pichurin; Grace Yoon; Michael Zech; Robert Jech; Juliane Winkelmann; Adriana S Beltran; Michael T Zimmermann; Brenda Temple; Sheryl S Moy; Eric W Klee; Queenie K-G Tan; Damaris N Lorenzo
Journal:  Nat Genet       Date:  2021-07-01       Impact factor: 41.307

10.  CADD: predicting the deleteriousness of variants throughout the human genome.

Authors:  Philipp Rentzsch; Daniela Witten; Gregory M Cooper; Jay Shendure; Martin Kircher
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.